Abstract Details

Title Dalfampiridine improves cognitive impairment in multiple sclerosis (MS): results from a randomised, double-blind, placebo-controlled trial

Topic Multiple Sclerosis

Presentation(s) S31 - (-)

Poster/Presentation
Number 001

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Laura De Giglio PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Luca Prosperini, MD	No disclosure on file
Maria Esmeralda Quartuccio	No disclosure on file
Giovanna Borriello	Giovanna Borriello has nothing to disclose.
Claudio Gasperini, MD	Dr. Gasperini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche, Merck, Genzyme, Novartis,Bayer, Teva, Almirall.
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.